Natl Toxicol Program Tech Rep Ser. 1988 Feb;334:1-158.
2-Amino-5-nitrophenol is used as a colorant in semipermanent hair dyes and in the manufacture of C.I. Solvent Red 8, an azo dye for synthetic resins, lacquers, and wood stains. 2-Amino-5-nitrophenol was nominated for toxicology and carcinogenesis studies by the National Cancer Institute because of widespread human exposure associated with its use in hair dyes. Toxicology and carcinogenesis studies were conducted by administering 2-amino-5-nitrophenol (98% pure) by gavage in corn oil 5 days per week to groups of F344/N rats and B6C3F1 mice of each sex in 16-day, 13-week, and 2-year studies. In the 2-year studies, male and female rats were given doses of 0, 100, or 200 mg/kg and male and female mice were given doses of 0, 400, or 800 mg/kg. Sixteen-Day and Thirteen-Week Studies: During the 16-day studies, F344/N rats of each sex received 0, 156, 313, 625, 1,250, or 2,500 mg/kg 2-amino-5-nitrophenol by gavage in corn oil vehicle. One of the five males that received 2,500 mg/kg, 1/5 females that received 1,250 mg/kg, and 2/5 females that received 313 mg/kg died before the end of the studies. Final mean body weights of rats that received 1,250 or 2,500 mg/kg were 11% and 30% lower than that of vehicle controls for males and 9% and 13% lower for females. B6C3F1 mice of each sex received doses of 0, 313, 625, 1,250, 2,500, or 5,000 mg/kg 2-amino-5-nitrophenol. Two of five males and 5/5 females that received 5,000 mg/kg, 3/5 males and 3/5 females that received 2,500 mg/kg, 3/5 females that received 1,250 mg/kg, 1/5 females that received 625 mg/kg, and 2/5 male vehicle controls died before the end of the studies. Final mean body weights of chemically exposed mice were not different from those of the vehicle controls. Rats that received 625, 1,250, or 2,500 mg/kg and male mice that received 5,000 mg/kg had loose stools. In 13-week studies, F344/N rats and B6C3F1 mice of both sexes received 0, 100, 200, 400, 800, or 1,600 mg/kg 2-amino-5-nitrophenol by gavage in corn oil. Five of 10 male and 2/10 female rats that received 1,600 mg/kg, 1/10 male and 3/10 female rats that received 800 mg/kg, and 1/10 male rats that received 400 mg/kg died before the end of the studies. Final mean body weights of males that received 400, 800, or 1,600 mg/kg were 10%, 25%, and 43% lower than that of vehicle controls. The final mean body weight of females that received 1,600 mg/kg was 16% lower that of vehicle controls. Four of 10 male and 3/10 female mice that received 1,600 mg/kg died before the end of the 13-week studies. The final mean body weight of male mice that received 1,600 mg/kg was 11% lower than that of vehicle controls; male and female mice that received 1,600 mg/kg appeared lethargic. During the 13-week studies, acute/chronic perivasculitis of vessels of the cecum and colon was observed in rats that received 400, 800, or 1,600 mg/kg and in mice that received 1,600 mg/kg. Body Weight and Survival in the Two-Year Studies: Mean body weights of rats receiving 200 mg/kg were 5%-10% lower than those of vehicle controls after week 33 for males and 4%-5% lower than those of vehicle controls after week 93 for females. Survival of male rats was significantly lower than that of vehicle controls after week 99 for the 100 mg/kg dose group and after week 75 for the 200 mg/kg dose group (final survival: vehicle control, 33/50; 100 mg/kg group, 16/50; 200 mg/kg group, 4/50). Survival of female rats was comparable to that of vehicle controls (30/50; 32/50; 29/50). Loose or poorly formed stools were observed for male rats and occasionally for females that received 200 mg/kg. Mean body weights of mice that received 800 mg/kg were 8%-11% lower than those of vehicle controls between weeks 29 and 74 for males and 8%-13% lower than those of vehicle controls after week 69 for females; mean body weights of mice that received 400 mg/kg were greater than those of vehicle controls after week 69 for males and 5%-9% lower than those of vehicle controls after week 69 for females. Survival of mice that received 800 mg/kg was significantly reduced compared with that of ose of vehicle controls after week 69 for females. Survival of mice that received 800 mg/kg was significantly reduced compared with that of vehicle controls after week 20 for males and week 22 for females and was not considered adequate to evaluate a carcinogenic response (final survival--male: vehicle control, 31/50; 400 mg/kg group, 36/50; 800 mg/kg group, 12/50; female: 37/50; 36/50; 10/50). Nonneoplastic and Neoplastic Effects in the Two-Year Studies: Pigmentation was present at increased incidences in all groups of chemically exposed animals and was characterized by varying amounts of an orange, granular pigment present in the fibrous connective tissue of the lamina propria, in the submucosa, and around vessels in the submucosa of the cecum and colon. Pigmentation of the rectum was observed at increased incidences in male rats that received 100 mg/kg, male and female rats that received 200 mg/kg, and both groups of chemically exposed mice. No pigmentation was found in the intestines of vehicle control rats or mice. Associated with pigmentation was an increased incidence of acute/chronic inflammation in the cecum and colon of all groups chemically exposed rats and mice; this inflammation was similar to that observed in the 13-week studies but was of greater severity. Acute/chronic inflammation was also present in the rectum of male rats that received 100 mg/kg, male and female rats that received 200 mg/kg, and male mice that received 800 mg/kg. The incidence of pancreatic acinar cell adenomas was significantly increased (P≤0.002) in male rats that received 100 mg/kg 2-amino-5-nitrophenol (vehicle control, 1/50; 100 mg/kg, 10/50; 200 mg/kg, 3/49); the increase was considered to be associated with chemical exposure. The reduced survival of male rats that received 200 mg/kg markedly reduced the sensitivity of this group for detecting the presence of neoplasms. The incidences of adenomas or carcinomas (combined) of the preputial or clitoral glands were marginally increased in male or female rats that received 200 mg/kg 2-amino-5-nitrophenol (preputial gland: 3/50; 2/50; 5/50; clitoral gland: 3/50; 3/50; 7/50). Neoplasms found in the intestinal tract of 3/50 male rats that received 100 mg/kg (one leiomyoma of the small intestine, one adenocarcinoma of the jejunum, one leiomyoma of the cecum), 2/50 male rats that received 200 mg/kg (one lipoma and one osteosarcoma of the cecum), and 1/50 female rats that received 200 mg/kg (one leiomyoma of the cecum) were not considered to be the result of chemical exposure. No compound-related neoplasms were found in mice exposed to 2-amino-5-nitrophenol in the 2-year studies. Genetic Toxicology: 2-Amino-5-nitrophenol was mutagenic in Salmonella typhimurium strains TA98, TA100, and TA1537 when tested in a preincubation protocol with and without exogenous metabolic activation, and it exhibited equivocal mutagenic activity in strain TA1535 in the presence of induced liver S9. 2-Amino-5-nitrophenol induced forward mutations in mouse L5178Y lymphoma cells in the absence of metabolic activation; it was not tested with S9. An increase in chromosomal aberrations and sister chromatid exchanges was observed in cultured Chinese hamster ovary (CHO) cells following incubation with 2-amino-5-nitrophenol both in the presence and absence of exogenous metabolic activation. Data Audit: The data, documents, and pathology materials from the 2-year studies of 2-amino-5-nitrophenol were audited at the NTP Archives. The audit findings show that the conduct of the studies is documented adequately and support the data and results given in this Technical Report. Conclusions: Under the conditions of these 2-year gavage studies, there was some evidence of carcinogenic activity for male F344/N rats that received 100 mg/kg 2-amino-5-nitrophenol, as shown by the increased incidence of acinar cell adenomas of the pancreas. Reduced survival of male F344/N rats that received 200 mg/kg decreased the sensitivity of this group for detecting a carcinogenic response. There was no evidence of carcinogenic activity for female rats that received 100 or 200 mg/kg per day. Marginally increased incidences of preputial or clitoral gland adenomas or carcinomas (combined) occurred in male and female F344/N rats administered 200 mg/kg 2-amino-5-nitrophenol. There was no evidence of carcinogenic activity for B6C3F1 mice that received 400 mg/kg 2-amino-5-nitrophenol; reduced survival of B6C3F1 mice that received 800 mg/kg caused this group to be considered inadequate for detecting a carcinogenic response.
2-氨基-5-硝基苯酚用作半永久性染发剂的着色剂,并用于制造C.I. 溶剂红8,一种用于合成树脂、漆和木材着色剂的偶氮染料。由于其在染发剂中的广泛使用导致人类广泛接触,美国国立癌症研究所提名对2-氨基-5-硝基苯酚进行毒理学和致癌作用研究。毒理学和致癌作用研究通过每周5天向每组F344/N大鼠和B6C3F1小鼠经口灌胃给予2-氨基-5-硝基苯酚(98%纯品)于玉米油中进行,研究为期16天、13周和2年。在2年研究中,雄性和雌性大鼠给予剂量为0、100或200mg/kg,雄性和雌性小鼠给予剂量为0、400或800mg/kg。
16天和13周研究:在16天研究期间,每组F344/N大鼠经口灌胃给予0、156、313、625、1250或2500mg/kg 2-氨基-5-硝基苯酚于玉米油载体中。接受2500mg/kg的5只雄性大鼠中的1只、接受1250mg/kg的5只雌性大鼠中的1只以及接受313mg/kg的5只雌性大鼠中的2只在研究结束前死亡。接受1250或2500mg/kg的雄性大鼠的最终平均体重比载体对照组低11%和30%,雌性大鼠低9%和13%。每组B6C3F1小鼠接受剂量为0、313、625、1250、2500或5000mg/kg 2-氨基-5-硝基苯酚。接受5000mg/kg的5只雄性大鼠中的2只和5只雌性大鼠、接受2500mg/kg的5只雄性大鼠中的3只和5只雌性大鼠、接受1250mg/kg的5只雌性大鼠中的3只、接受625mg/kg的5只雌性大鼠中的1只以及2只雄性载体对照组小鼠在研究结束前死亡。化学暴露小鼠的最终平均体重与载体对照组无差异。接受625、1250或2500mg/kg的大鼠以及接受5000mg/kg的雄性小鼠出现稀便。在13周研究中,两性的F344/N大鼠和B6C3F1小鼠经口灌胃给予0、100、200、400、800或1600mg/kg 2-氨基-5-硝基苯酚于玉米油中。接受1600mg/kg的10只雄性大鼠中的5只和10只雌性大鼠中的2只、接受800mg/kg的10只雄性大鼠中的1只和10只雌性大鼠中的3只以及接受400mg/kg的10只雄性大鼠中的1只在研究结束前死亡。接受400、800或1600mg/kg的雄性大鼠的最终平均体重比载体对照组低10%、25%和43%。接受1600mg/kg的雌性大鼠的最终平均体重比载体对照组低16%。接受1600mg/kg的10只雄性小鼠中的4只和10只雌性小鼠中的3只在13周研究结束前死亡。接受1600mg/kg的雄性小鼠的最终平均体重比载体对照组低11%;接受1600mg/kg的雄性和雌性小鼠表现出嗜睡。在13周研究期间,接受400、800或1600mg/kg的大鼠以及接受1600mg/kg的小鼠的盲肠和结肠血管出现急性/慢性血管周围炎。
接受200mg/kg的雄性大鼠在第33周后平均体重比载体对照组低5%-10%;接受200mg/kg的雌性大鼠在第93周后平均体重比载体对照组低4%-5%。接受100mg/kg剂量组的雄性大鼠在第99周后存活率显著低于载体对照组,接受200mg/kg剂量组的雄性大鼠在第75周后存活率显著低于载体对照组(最终存活率:载体对照组,33/50;100mg/kg组,16/50;200mg/kg组,4/50)。雌性大鼠的存活率与载体对照组相当(30/50;32/50;29/50)。接受200mg/kg的雄性大鼠以及偶尔接受200mg/kg的雌性大鼠出现稀便或大便成形不良。接受800mg/kg的雄性小鼠在第29周至74周期间平均体重比载体对照组低8%-11%,雌性小鼠在第69周后平均体重比载体对照组低8%-13%;接受400mg/kg的雄性小鼠在第69周后平均体重大于载体对照组,雌性小鼠在第69周后平均体重比载体对照组低5%-9%。接受800mg/kg的雌性小鼠在第69周后存活率与载体对照组相比显著降低。接受8